Vantage logo

Alexion ticks Astra’s boxes

The deal solves several problems for Astra, and ranks as biopharma’s fifth-biggest cross-border transaction.

Vantage logo

Finding the next Vertex

Other groups with large disconnects between sellside and investor expectations include Beigene, Alnylam and Acceleron.